Adimab, LLC

Insider profile

Adimab, LLC's trades of Invivyd Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-12-23 2025-12-23 PrS Proposed sale
99,308
13.00
US$2,398,687
99,308 13.00 US$2,398,687
2025-11-17 2025-11-17 PrS Proposed sale
50,317
101.98
US$3,319,508
50,317 101.98 US$3,319,508
2024-01-22 2024-01-19 S Sale
69,772 +37.5%
59.49
US$4,661,454
69,772 +37.5% 59.49 US$4,661,454
2024-01-19 2024-01-19 PrS Proposed sale
5,000,000
3.95
US$19,750,000
5,000,000 3.95 US$19,750,000